Angel Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.90 M
as on 24-10-2024
- Company Age 50 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.50 M
as on 24-10-2024
- Revenue 88.66%
(FY 2023)
- Profit -4169.85%
(FY 2023)
- Ebitda -266.33%
(FY 2023)
- Net Worth -454.87%
(FY 2023)
- Total Assets 21.47%
(FY 2023)
About Angel Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.90 M.
The company currently has active open charges totaling ₹7.50 M.
Sajal Bhatta, Swapan Bhatta, and Tapas Bhatta serve as directors at the Company.
- CIN/LLPIN
U27109WB1974PTC029618
- Company No.
029618
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Aug 1974
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Angel Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sajal Bhatta  | Director | 22-May-2006 | Current |
| Swapan Bhatta | Director | 22-May-2006 | Current |
| Tapas Bhatta | Director | 27-Jan-2016 | Current |
Financial Performance of Angel Laboratories.
Angel Laboratories Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 88.66% increase. The company also saw a substantial fall in profitability, with a 4169.85% decrease in profit. The company's net worth observed a substantial decline by a decrease of 454.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Angel Laboratories?
In 2023, Angel Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mahanagar Projects Private LimitedActive 22 years 7 monthsSajal Bhatta and Swapan Bhatta are mutual person
- Sps Infrarealty Private LimitedActive 13 years 9 months
Sajal Bhatta and Swapan Bhatta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Mar 2011 | ₹7.50 M | Open |
How Many Employees Work at Angel Laboratories?
Angel Laboratories has a workforce of 11 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Angel Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Angel Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
